BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 31928821)

  • 21. Ten Years' Experience in Robotic-Assisted Thoracic Surgery for Early Stage Lung Cancer.
    Casiraghi M; Galetta D; Borri A; Tessitore A; Romano R; Diotti C; Brambilla D; Maisonneuve P; Spaggiari L
    Thorac Cardiovasc Surg; 2019 Oct; 67(7):564-572. PubMed ID: 29605962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
    Chan EG; Chan PG; Mazur SN; Normolle DP; Luketich JD; Landreneau RJ; Schuchert MJ
    J Thorac Cardiovasc Surg; 2021 May; 161(5):1639-1648.e2. PubMed ID: 32331817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller?
    Okada M; Yoshikawa K; Hatta T; Tsubota N
    Ann Thorac Surg; 2001 Mar; 71(3):956-60; discussion 961. PubMed ID: 11269480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Node-Positive Segmentectomy for Non-Small-Cell Lung Cancer: Risk Factors and Outcomes.
    Lutfi W; Schuchert MJ; Dhupar R; Ekeke C; Sarkaria IS; Christie NA; Luketich JD; Okusanya OT
    Clin Lung Cancer; 2019 Jul; 20(4):e463-e469. PubMed ID: 31031205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer.
    Tezel C; Dogruyol T; Alpay L; Akyıl M; Evman S; Metin S; Baysungur V; Yalcinkaya I
    Thorac Cardiovasc Surg; 2020 Mar; 68(2):183-189. PubMed ID: 30388719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
    Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lobectomy Versus Stereotactic Body Radiotherapy in Healthy Octogenarians With Stage I Lung Cancer.
    Razi SS; Kodia K; Alnajar A; Block MI; Tarrazzi F; Nguyen D; Villamizar N
    Ann Thorac Surg; 2021 May; 111(5):1659-1665. PubMed ID: 32891656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer.
    Tsubokawa N; Tsutani Y; Miyata Y; Handa Y; Misumi K; Hanaki H; Hida E; Okada M
    World J Surg; 2018 Aug; 42(8):2493-2501. PubMed ID: 29423740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ki-67 labeling index is associated with recurrence after segmentectomy under video-assisted thoracoscopic surgery in stage I non-small cell lung cancer.
    Yamashita S; Moroga T; Tokuishi K; Miyawaki M; Chujo M; Yamamoto S; Kawahara K
    Ann Thorac Cardiovasc Surg; 2011; 17(4):341-6. PubMed ID: 21881319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
    Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
    Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes.
    Roman M; Labbouz S; Valtzoglou V; Ciesla A; Hawari M; Addae-Boateng E; Thorpe JA; Duffy JP; Majewski A
    Eur J Surg Oncol; 2019 May; 45(5):845-850. PubMed ID: 30409440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer.
    Thomas DC; Arnold BN; Rosen JE; Salazar MC; Detterbeck FC; Blasberg JD; Boffa DJ; Kim AW
    World J Surg; 2018 Jan; 42(1):161-171. PubMed ID: 28799084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.
    Landreneau RJ; Normolle DP; Christie NA; Awais O; Wizorek JJ; Abbas G; Pennathur A; Shende M; Weksler B; Luketich JD; Schuchert MJ
    J Clin Oncol; 2014 Aug; 32(23):2449-55. PubMed ID: 24982447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Segmentectomy vs Lobectomy for Early Non-Small Cell Lung Cancer With Visceral Pleural Invasion.
    Mathey-Andrews C; Abruzzo AR; Venkateswaran S; Potter AL; Senthil P; Beqari J; Yang CJ; Lanuti M
    Ann Thorac Surg; 2024 May; 117(5):1007-1014. PubMed ID: 37419171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.